A detailed history of Heron Bay Capital Management transactions in Compugen LTD stock. As of the latest transaction made, Heron Bay Capital Management holds 12,547 shares of CGEN stock, worth $21,204. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,547
Holding current value
$21,204
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.75 - $2.95 $21,957 - $37,013
12,547 New
12,547 $32,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $146M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Heron Bay Capital Management Portfolio

Follow Heron Bay Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Heron Bay Capital Management with notifications on news.